Future burden of vision loss in Australia: Projections from the National Eye Health Survey.


Journal

Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531

Informations de publication

Date de publication:
08 2020
Historique:
received: 09 01 2020
revised: 17 04 2020
accepted: 24 04 2020
pubmed: 5 5 2020
medline: 1 9 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

Projections of Australia's future burden of vision loss will inform eye health service delivery. This study aimed to forecast bilateral vision loss in Australia from 2020 to 2050. Population-based survey. Indigenous and non-indigenous Australians (n = 4253) aged ≥50 years from the National Eye Health Survey (NEHS, 2015-2016). Using the age-and-sex-stratified prevalence of vision loss (better eye visual acuity <6/12) from the NEHS, the prevalence of, and number of people aged ≥50 years with, vision loss were forecast to 2050 using Australian census projections. Prevalence of, and number of Australians with, vision loss from 2020 to 2050. The prevalence of vision loss is predicted to increase from 6.7% to 7.5% by 2050. Owing to population dynamics, the estimated number of Australians ≥50 years old with vision loss will nearly double from 532 386 in 2016 to 1 015 021 in 2050. The greatest increase in vision loss is expected to occur in those aged ≥80 years (2.6-fold, 2016 = 144 240; 2050 = 376 296). The number of people with uncorrected refractive error is projected to increase 1.7-fold, from 331 914 in 2016 to 578 969 in 2050. Due to population growth and ageing, the future burden of vision loss in Australia is likely to increase, but the magnitude of this change is uncertain due to a lack of available data on some relevant input variables. Nonetheless, efforts are required to ensure early detection and treatment of major eye conditions, particularly treatable conditions such as uncorrected refractive error and cataract.

Sections du résumé

IMPORTANCE
Projections of Australia's future burden of vision loss will inform eye health service delivery.
BACKGROUND
This study aimed to forecast bilateral vision loss in Australia from 2020 to 2050.
DESIGN
Population-based survey.
PARTICIPANTS
Indigenous and non-indigenous Australians (n = 4253) aged ≥50 years from the National Eye Health Survey (NEHS, 2015-2016).
METHODS
Using the age-and-sex-stratified prevalence of vision loss (better eye visual acuity <6/12) from the NEHS, the prevalence of, and number of people aged ≥50 years with, vision loss were forecast to 2050 using Australian census projections.
MAIN OUTCOME MEASURE
Prevalence of, and number of Australians with, vision loss from 2020 to 2050.
RESULTS
The prevalence of vision loss is predicted to increase from 6.7% to 7.5% by 2050. Owing to population dynamics, the estimated number of Australians ≥50 years old with vision loss will nearly double from 532 386 in 2016 to 1 015 021 in 2050. The greatest increase in vision loss is expected to occur in those aged ≥80 years (2.6-fold, 2016 = 144 240; 2050 = 376 296). The number of people with uncorrected refractive error is projected to increase 1.7-fold, from 331 914 in 2016 to 578 969 in 2050.
CONCLUSIONS AND RELEVANCE
Due to population growth and ageing, the future burden of vision loss in Australia is likely to increase, but the magnitude of this change is uncertain due to a lack of available data on some relevant input variables. Nonetheless, efforts are required to ensure early detection and treatment of major eye conditions, particularly treatable conditions such as uncorrected refractive error and cataract.

Identifiants

pubmed: 32363784
doi: 10.1111/ceo.13776
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

730-738

Informations de copyright

© 2020 Royal Australian and New Zealand College of Ophthalmologists.

Références

Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888-e897.
Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545-1602.
Access Economics-prepared for AMD Alliance International. The Global Economic Cost of Visual Impairment. 2010. http://www.icoph.org/dynamic/attachments/resources/globalcostofvi_finalreport.pdf.
Commonwealth of Australia. National Framework for Action to Promote Eye Health and Prevent Avoidable Blindness and Vision Loss. Canberra, Australia: Australian Government Department of Health; 2005.
Foreman J, Xie J, Keel S, Taylor HR, Dirani M. Utilization of eye health-care services in Australia: the National Eye Health Survey. Clin Experiment Ophthalmol. 2018;46(3):213-221.
Foreman J, Xie J, Keel S, et al. The Prevalence and causes of vision loss in indigenous and non-indigenous Australians: the National Eye Health Survey. Ophthalmology. 2017;124(12):1743-1752.
WHO. Universal eye health: a global action plan 2014-19. 2013. http://www.who.int/blindness/AP2014_19_English.pdf?ua=1. Accessed September 2016.
ABS. Australian Statistical Geography Standard (ASGS). 2014. http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Australian+Statistical+Geography+Standard+(ASGS).
Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.
Magliano DJ, Shaw JE, Shortreed SM, et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia. 2008;51(12):2179-2186.
Taylor HR, Keeffe JE, Vu HT, et al. Vision loss in Australia. Med J Aust. 2005;182(11):565-568.
Foran S, Mitchell P, Wang JJ. Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains eye study. Ophthalmology. 2003;110(1):41-50.
Dimitrov PN, Mukesh BN, McCarty CA, Taylor HR. Five-year incidence of bilateral cause-specific visual impairment in the Melbourne visual impairment project. Invest Ophthalmol Vis Sci. 2003;44(12):5075-5081.
Foreman J, Xie J, Keel S, et al. The Prevalence and causes of vision loss in indigenous and non-indigenous Australians: the National Eye Health Survey. Ophthalmology. 2017;124(12):1743-1752.
Foreman J, Keel S, Dunn R, van Wijngaarden P, Taylor HR, Dirani M. Sampling methodology and site selection in the National Eye Health Survey: an Australian population-based prevalence study. Clin Experiment Ophthalmol. 2016;45(4):336-347.
Foreman J, Keel S, van Wijngaarden P, Taylor HR, Dirani M. Recruitment and testing protocol in the National Eye Health Survey: a population-based eye study in Australia. Ophthalmic Epidemiol. 2017;24(6):353-363.
ABS. Population projections, Australia, 2017-(base)-2066-cat. no. 3222.0. 2018. https://www.abs.gov.au. Accessed February 25, 2019.
ABS. Demographic estimates and projections: concepts, sources and methods, 1999, cat. no. 3228.0., https://www.abs.gov.au. Accessed February 25, 2019.
ABS. Census TableBuilder, 2019. http://www.abs.gov.au. Accessed January 15, 2019.
ABS. Census of population and housing: reflecting Australia-Stories from the Census, 2016. Accessed 5th of March, 2019.
Healy E, Kiely PM, Arunachalam D. Optometric supply and demand in Australia: 2011-2036. Clin Exp Optom. 2015;98(3):273-282.
Kiely PM, Chakman J. Optometric practice in Australian standard geographical classification-remoteness areas in Australia, 2010. Clin Exp Optom. 2011;94(5):468-477.
ABS. Australian historical population statistics, 2014. ABS cat. no. 3105.0.65.001. https://www.abs.gov.au/ausstats/abs@.nsf/mf/3105.0.65.0012014. Accessed March 2019.
AIHW. Deaths in Australia. 2018. Accessed March 5, 2019. https://www.aihw.gov.au/reports/life-expectancy-death/deaths-in-australia/contents/summary.
Foreman J, Keel S, Dirani M. Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey. Med J Aust. 2018;208(2):97.
Foreman J, Xie J, Keel S, Taylor HR, Dirani M. Treatment coverage rates for refractive error in the National Eye Health survey. PLoS One. 2017;12(4):e0175353.
Foreman J, Xie J, Keel S, Taylor HR, Dirani M. Utilization of eye health-care services in Australia: the National Eye Health Survey. Clin Experiment Ophthalmol. 2017;46(3):213-221.
Foreman J, Xie J, Keel S, et al. Cataract surgery coverage rates for indigenous and non-indigenous Australians: the National Eye Health Survey. Med J Aust. 2017;207(6):256-261.
Varma R, Vajaranant TS, Burkemper B, et al. Visual impairment and blindness in adults in the United States: demographic and geographic variations from 2015 to 2050. JAMA Ophthalmol. 2016;134(7):802-809.
UN. World population prospects: the 2017 revision. https://esa.un.org/unpd/wpp/publications/files/wpp2017_keyfindings.pdf2017.
Australian Bureau of Statistics. Life tables for Aboriginal and Torres Strait Islander Australians, 2015-2017. 2018. https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/3302.0.55.003~2015-2017~Main%20Features~Life%20expectancy%20at%20birth%20of%20Aboriginal%20and%20Torres%20Strait%20Islander%20Australians~5.
KeepSight. KeepSight, 2019. https://www.keepsight.org.au/.
Australian Government Department of Health. Budget 2016-2017: Portfolio Budget Statements 2016-2017; Budget-Related Paper No1.10. Health Portfolio. Canberra, Australia: Australian Government Department of Health; 2016.
Australian Government Department of Health. Implementation Plan under the National Framework for Action to Promote Eye Health and Prevent Avoidable Blindness and Vision Loss. Canberra, Australia; Australian Government Department of Health; 2014.
Australian Bureau of Statistics. National Health Survey: first results, 2017-2018-Diabetes mellitus, 2018. https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4364.0.55.001~2017-18~Main%20Features~Diabetes%20mellitus~50.

Auteurs

Joshua Foreman (J)

Centre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
Department of Surgery, Ophthalmology, University of Melbourne, Melbourne, Australia.

Stuart Keel (S)

Centre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
Department of Surgery, Ophthalmology, University of Melbourne, Melbourne, Australia.

Myra McGuiness (M)

Centre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne, Australia.

Danny Liew (D)

School of Population Health and Preventive Medicine, Monash University, Melbourne, Australia.

Peter van Wijngaarden (P)

Centre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
Department of Surgery, Ophthalmology, University of Melbourne, Melbourne, Australia.

Hugh R Taylor (HR)

Indigenous Eye Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Mohamed Dirani (M)

Centre for Eye Research Australia, Royal Victorian Eye & Ear Hospital, Melbourne, Australia.
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH